90 results on '"Winsel K"'
Search Results
2. Zur Komplexbildung des Nickel(II) mit 2-Äthyl-1,2-diaminobutan
3. Säuredissoziationskonstanten des protonierten 2-Äthyl-1,2-diaminobutans
4. Novel Method and Parameters for Testing and Characterization of Foam Stability
5. Dynamic surface tension and surface area elasticity of adsorbed pulmonary surfactant layers
6. Bioluminescence Reactions of Nucleotides Part 2: Investigations of AMP/ATP Solutions in the Luciferin/Luciferase System
7. Bioluminescence Reactions of Nucleotides Part 1 Studies of Different Nucleotides
8. Application of Bromhexine Metabolite VIII (NA 872) and Bromhexine-Glucose in Treatment of Adult Respiratory Distress Syndrome.
9. Synthese von Triorgano-amido-arsen-, -antimon- und -wismut-halogeniden.
10. Metallorganische Peroxide. VIII. Zum Mechanismus der Zersetzung von Bis-organoantimonyl-peroxiden. Teil II.
11. Metallorganische Peroxide, VII. Zum Mechanismus der Zersetzung von Bis-organoantimonyl-peroxiden. Teil I.
12. Herstellung markierter Antituberkulotika zur Klärung spezifischer Fragestellungen bei der Therapieoptimierung II. Mitt. Darstellung von [ H]-Rifampicin ([ H]-RMP), Prüfung der Stabilität der Markierung und Herstellung eines oral verabreichbaren [ H]-RMP-Präparates
13. Herstellung markierter Antituberkulotika zur Klarung spezifischer Fragestellungen bei der Therapieoptimierung II. Mitt. Darstellung von [3H]-Rifampicin ([3H]-RMP), Prufung der Stabilitat der Markierung und Herstellung eines oral verabreichbaren [3H]-RMP-Praparates
14. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects
15. Herstellung markierter Antituberkulotika zur Klärung spezifischer Fragestellungen bei der Therapieoptimierung I. Mitt. Darstellung von [ H]-Isonicotinsäurehydrazid ([ H]-INH), Herstellung injizierbarer Lösungen, Prüfung der Stabilität der Markierung
16. Herstellung markierter Antituberkulotika zur Klärung spezifischer Fragestellungen bei der Therapieoptimierung II. Mitt. Darstellung von [3H]-Rifampicin ([3H]-RMP), Prüfung der Stabilität der Markierung und Herstellung eines oral verabreichbaren [3H]-RMP-Präparates
17. Experimental investigations in Adult Respiratory Distress Syndrome (ARDS). Repeated pulmonary lavage in LEWE-mini-pigs
18. ChemInform Abstract: ORGANOMETALLIC PEROXIDES. VII. MECHANISM OF THE DECOMPOSITION OF BISORGANOANTIMONYL PEROXIDES. PART I
19. Gas exchange, pulmonary mechanics and haemodynamics in adult respiratory distress syndrome: experimental results in Lewe miniature pigs
20. ChemInform Abstract: SYNTHESIS OF TRIORGANOAMIDOARSENIC, ‐ANTIMONY, AND ‐BISMUTH HALIDES
21. Herstellung markierter Antituberkulotika zur Klärung spezifischer Fragestellungen bei der Therapieoptimierung I. Mitt. Darstellung von [3H]-Isonicotinsäurehydrazid ([3H]-INH), Herstellung injizierbarer Lösungen, Prüfung der Stabilität der Markierung
22. Herstellung markierter Antituberkulotika zur Klarung spezifischer Fragestellungen bei der Therapieoptimierung I. Mitt. Darstellung von [3H]-Isonicotinsaurehydrazid ([3H]-INH), Herstellung injizierbarer Losungen, Prufung der Stabilitat der Markierung
23. Bioluminescence Reactions of Nucleotides Part 2: Investigations of AMP/ATP Solutions in the Luciferin/Luciferase System
24. Bioluminescence Reactions of Nucleotides Part 1 Studies of Different Nucleotides
25. Novel method and parameters for testing and characterization of foam stability.
26. Quantitative Brewster angle microscopy of the surface film of human broncho-alveolar lavage fluid.
27. [Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways].
28. [The antioxidative and inflammation inhibiting properties of ambroxol].
29. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
30. [Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].
31. [Clinical pharmacology in optimization of therapy of lung diseases].
32. [Chemiluminescence measurements of bronchoalveolar lavage cells in patients with collagenosis].
33. Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome.
34. [Laboratory equipment for the radioimmunologic determination of IgE].
35. [Morphological demonstration of phospholipids in the lung (author's transl)].
36. [The effect of ambroxol and bromhexine on the "respiratory burst" of alveolar macrophages].
37. [The lipids of the lungs in experimental aspiration pneumonitis (author's transl)].
38. [Function, composition, biosynthesis and degradation of the surfactant system (anti-atelectasis factor) of the lung].
39. [Clinico-experimental studies of therapy optimization in kidney tuberculosis].
40. [Tracheal instillation of arachidonic acid as an asthma model in guinea pigs--preliminary results of the effect of inhibitors of arachidonic acid metabolism].
41. [Bronchoalveolar lavage].
42. [Ultrastructural and autoradiographical investigations of early changes in experimental lung fibrosis (author's transl)].
43. [Article in addition of the differentiated diagnostics of chylous pleural effusions (author's transl)].
44. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
45. [Quantitative determination of alpha1-antitrypsin in lung tissue from adults with emphysema and newborns with respiratory-distress-syndrome (author's transl)].
46. [Ultrasonic atomization of surface-active agents from lung tissue and lecithin dispersions with reference to the artificial spraying of lungs].
47. [Experimental respiratory distress syndrome after injection anti-pulmonary serum. III. Respiratory-mechanical, blood gas-analysis, physico-chemical and biochemical findings in chronic tests: attempts at therapy].
48. [Physiopathology and biochemistry in the acute respiratory distress syndrome--animal experiment studies].
49. [Extracorporeal lung perfusion in experimental canine lung transplantation (author's transl)].
50. [Changes of biochemical processes of the lungs caused by air pollutants (author's transl)].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.